Drugs that contain Sorafenib Tosylate

1. Drug name - NEXAVAR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8877933 BAYER HLTHCARE Thermodynamically stable form of a tosylate salt
Dec, 2027

(5 years from now)

CN101065360B BAYER HLTHCARE Bay43-9006 Toluene Sulfonate Of Thermodynamically Stable Form
Sep, 2025

(2 years from now)

CN101065360A BAYER HLTHCARE Thermodynamics Stabilizing Form Of Bay43-9006 Toluenesulfonate
Sep, 2025

(2 years from now)

EP1797038B1 BAYER HLTHCARE Thermodynamically Stable Form Of Bay 43-9006 Tosylate
Sep, 2025

(2 years from now)

EP1797038A1 BAYER HLTHCARE Thermodynamically Stable Form Of Bay 43-9006 Tosylate
Sep, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8618141 BAYER HLTHCARE Aryl ureas with angiogenesis inhibiting activity Feb, 2023

(4 months from now)

US9737488 BAYER HLTHCARE Pharmaceutical composition for the treatment of cancer Sep, 2028

(5 years from now)

Treatment: Treatment of advanced renal cell carcinoma; Treatment of locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment; treatment of advanced renal cell carcinoma; treatment of unresectable hepatocellular carcinoma

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 200MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.